Clinical trial
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
NCT00173680 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00173680 |
|---|---|
| Title | Methylation Status of CD44 Promoter Region in Primary Lung Cancer |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Non-Small Cell Lung Cancer |
| Enrollment | 40 |
| Start date | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 24, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: